Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata affects quality of life more than androgenetic alopecia.

Effective hair loss treatment in women requires correct diagnosis and can include medications like minoxidil, antiandrogens, and treatments for underlying conditions like PCOS.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Hair diversity is influenced by complex genetics and environmental factors, requiring more research for practical solutions.

Premature hair graying in young men is linked to family history, obesity, and smoking.

Plasmacytoid dendritic cells are a key factor in causing hair loss in alopecia areata and could help differentiate it from other hair loss conditions.

Men with more vanadium in their blood and who drink less soy milk are more likely to have hair loss.

The document concludes that diagnosing and treating hair loss is complex and requires understanding its psychological effects and underlying causes, while also calling for more research and new treatments.

Levetiracetam may cause hair loss, which can potentially reverse with lower doses or stopping the drug.

Clobetasol and pimecrolimus are similarly effective for alopecia areata, but pimecrolimus has fewer side effects and is preferred for long-term use.

Low-Level Laser Therapy and other light treatments for hair growth lack strong evidence and need more research.

New mutations in the SLC39A4 gene found in twins help understand the genetic cause of acrodermatitis enteropathica.

Calcipotriol works almost as well as clobetasol for mild to moderate alopecia areata with fewer side effects.

Adolescents with severe alopecia incur significantly higher healthcare costs.

Higher doses of spironolactone may improve acne in PCOS patients, but side effects are a concern.

Corticosteroids are the most common treatment for alopecia areata, but many patients need better options.

PRP combined with minoxidil is the most effective treatment for hair growth in androgenetic alopecia.

Alopecia areata severely impacts quality of life, mental health, and work productivity.

The Middle East and Africa need better data, treatment consensus, and support for Alopecia Areata.

Diphenylcyclopropenone is more effective and has fewer side effects than dinitrochlorobenzene for treating alopecia areata.

Gender affects hair and scalp characteristics, with differences in hormone responses, graying patterns, and trace metals.

PRP injections can effectively treat alopecia areata.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

The research found that Atypical Progeroid Syndrome has unique symptoms and is not caused by the buildup of a certain mutant protein.

The document concludes that hair is complex, with a detailed growth cycle, structure, and clinical importance, affecting various scientific and medical fields.

People with alopecia areata often have other health issues like skin diseases, metabolic syndrome, stomach infections, lupus, anemia, thyroid problems, mental health issues, vitamin D deficiency, and hearing and eye problems.

EDA2R gene linked to hair loss.

The study suggests that motor neurons created from stem cells of patients with spinal and bulbar muscular atrophy show signs of the disease, including changes in protein levels and cell functions.